Beranda › Kondisi Pasca-COVID (Long COVID) › Alabama
Uji klinis Kondisi Pasca-COVID (Long COVID) di Alabama
7 studi untuk Kondisi Pasca-COVID (Long COVID) mencari peserta di lokasi di Alabama.
Kota di Alabama
Teks studi resmi (Bahasa Inggris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Birmingham
- Research Site, Mobile
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- University of Alabama at Birmingham, Huntsville Regional Medical Campus (HRMC), Huntsville
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Anniston
Menerima pesertaFase 1
Usia 65 hingga 85 · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT07464314REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
- University of Alabama at Birmingham, Birmingham
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Mei 2026 · NCT05218083Long COVID Brain Fog: Cognitive Rehabilitation Trial
- University of Alabama at Birmingham, Birmingham
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06095297Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
- AFC Montclair, Birmingham
- AFC Madison, Madison
Menerima pesertaSukarelawan sehat diterima
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2025 · NCT06744660Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
- University of South Alabama, Mobile
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Mei 2021 · NCT04445285Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.